abstract |
The present invention provides pharmaceutical compositions comprising an iRNA agent, e.g., a double-stranded ribonucleic acid (dsRNA) agent, and the composition for treating a hemorrhagic event in a subject with hemophilia (e.g., with or without an inhibitor). about how to use it. |